Diagnosticos Da America SA operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Diagnosticos Da America SA with three other
pharmaceutical manufacturers in Latin America:
Genomma Lab Internacional Sab De Cv
of MEXICO
(2019
sales of 12.76 billion Mexican Pesos [US$537.79 million]
),
Fleury SA
(2.91 billion Brazilian Reals [US$558.13 million]
of which 84%
was Diagnostic Medicine), and
Hypera SA
(3.29 billion Brazilian Reals [US$632.99 million]
).
Sales Analysis.
Diagnosticos Da America SA reported sales of 4.36 billion Brazilian Reals (US$838.52 million)
for the
year ending
December of 2019.
This
represents
an
increase of 11.0%
versus 2018, when the company's sales were 3.93 billion Brazilian Reals.
Sales at Diagnosticos Da America SA have increased during each of the previous five years
(and since 2014, sales have increased a total of 62%).